Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pirfenidone in Idiopathic Pulmonary Fibrosis
CTR20131983Phase 3Active
- Sponsor
- Shandong Bainuo Pharmaceutical
- Start
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of pirfenidone in idiopathic pulmonary fibrosis (IPF), sponsored by Shandong Bainuo Pharmaceutical. Started May 2014; status: active.
02
Drugs
pirfenidone
03
Conditions
idiopathic pulmonary fibrosis (IPF)
Beyond the preview
Go deeper on CTR20131983.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20131983.